Plaza S.A. (SNSE:MALLPLAZA)

Inozyme Pharma Cash Flow Statement

Financials in millions CLP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	352,305	335,934	349,759	157,667	46,556	12,248
Depreciation & Amortization	231.82	380.82	315.76	296.96	54,303	52,540
Other Amortization	2,452	1,731	1,838	1,868	-	-
Other Operating Activities	-3,732	-37,224	-56,862	115,470	119,231	19,136
Operating Cash Flow	351,256	300,822	295,050	275,302	220,089	83,924
Operating Cash Flow Growth	22.06%	1.96%	7.17%	25.09%	162.25%	-62.36%
Acquisition of Real Estate Assets	-71,348	-73,999	-117,518	-113,440	-70,284	-89,253
Net Sale / Acq. of Real Estate Assets	-71,348	-73,999	-117,518	-113,440	-70,284	-89,253
Cash Acquisition	-400,380	-400,380	-	-	-	-18,422
Other Investing Activities	25,463	26,398	23,396	17,440	1,759	2,521
Investing Cash Flow	-449,323	-450,303	-95,741	-97,988	-70,109	-106,438
Long-Term Debt Issued	-	108,231	-	238,007	15,229	435,221
Long-Term Debt Repaid	-	-106,882	-123,995	-85,374	-232,190	-187,090
Net Debt Issued (Repaid)	33,420	1,348	-123,995	152,633	-216,961	248,131
Issuance of Common Stock	308,426	308,426	-	-	-	-
Common Dividends Paid	-125,751	-125,751	-11.35	-45,410	-8,774	-31,681
Other Financing Activities	-59,824	-57,025	-186,958	-107,617	-2,214	-24,641
Foreign Exchange Rate Adjustments	-4,404	-358.71	11,908	-182.96	479.58	-2,503
Net Cash Flow	53,802	-22,842	-99,747	176,736	-77,488	166,792
Cash Interest Paid	57,862	54,432	55,568	45,184	34,027	35,152
Cash Income Tax Paid	51,054	51,054	24,215	9,073	-5,097	12,684
Levered Free Cash Flow	206,815	175,801	291,941	57,353	133,454	24,130
Unlevered Free Cash Flow	244,339	210,042	320,932	86,995	155,697	46,148
Change in Net Working Capital	14,292	27,091	-116,866	94,612	-12,197	46,725

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.